Skip to main content
Premium Trial:

Request an Annual Quote

Filing Regulations Force Orchid to Delays Q4 and 2005 Reports

NEW YORK, March 30 (GenomeWeb News) - Orchid Cellmark will delay the filing of its fourth-quarter and full-year 2005 earnings reports with the US Securities and Exchange commission due to audit requirements associated with the Sarbanes-Oxley Act of 2002.


Orchid originally planned to issue financial results on March 30, and the firm intends to announce a new date "as soon as possible," according to the statement.


The legislation, which opponents call costly and complex, has caused several small publicly traded companies to delay their recent filings, though the SEC has generally allowed this. Supporters say it can protect investors and employees from corporate fraud.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.